Annals of Intensive Care
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study
Posted on
OUr founders
ISO 9001 Certified
OUr Institutionnal Supporters
Our network
Foundation for innovation
in Cardiometabolism and Nutrition
